Indications

This product has been shown to be effective for the vaccination of healthy 18 day old chicken embryos or chickens 1 day of age or older against standard and variant infectious bursal disease.

Advantages*

• The first live IBD vaccine for day-of-age use that fully protects against standard, Delaware and GLS IBD strains.
• The only attenuated IBD vaccine which retains all Delaware variant characteristics including reaction with the neutralizing 67 monoclonal antibody markers.
• Approved for use in-ovo.
• Approved for subcutaneous use at day of age with Intervet Marek’s vaccines.
• Does not spread bird-to-bird or revert to virulence.
• No bursal damage and resultant immunosuppression.
• Numerous field studies demonstrate improved feed efficiencies, weight gains, lower mortality and fewer birds condemned at the processing plant.

Diseases/Parasites

• Infectious Bursal disease (IBD)

Vaccination Programs

Many factors must be considered in determining the vaccination program for a particular farm or poultry operation. To be fully effective, the vaccine must be administered to healthy receptive birds held in proper environment under good management. In addition, the response may be modified by the age of the birds and their immune status. Seldom does 1 vaccination under field conditions produce complete protection for all individuals in a given flock. The amount of protection required will vary with the type of operation and the degree of exposure that a flock is likely to encounter.

Administration

1. For in ovo administration: inoculate each 18-day-old chicken embryo with a full dose (0.05 ml or 0.1ml). For subcutaneous administration: inoculate each day-old chicken with a full dose (0.2 ml).
2. Use entire contents of diluent bag within 1 hour after mixing.
3. After reconstitution, the vaccine should be kept cool and gently agitated frequently.

Supplied

1 x 4,000 doses ampules

Caution

It is recommended that good management practices be followed to reduce exposure to infectious bursal disease for at least three weeks following vaccination.

1. VACCINATE ONLY HEALTHY CHICKENS AND CHICKEN EMBRYOS.
2. Do not mix with other products, except as specified on this label.
3. Store vaccine in liquid nitrogen at a temperature below -150°C (-238°F).
4. ONCE THAWED, THE PRODUCT SHOULD NOT BE REFROZEN.
5. Do not vaccinate within 21 days before slaughter.
6. Contains gentamicin as a preservative.
7. Inactivate unused contents before disposal.
8. In case of human exposure, contact a physician.
9. FOR ANIMAL USE ONLY.

Notice

This vaccine has undergone rigid potency, safety and purity tests, and meets Merck Animal Health, U.S. and local regulatory requirements. It is designed to stimulate effective immunity when used as directed, but the user must be advised that the response to the product depends upon many factors, including, but not limited to, conditions of storage and handling by the user, administration of the vaccine, health and responsiveness of the individual chickens and the degree of field exposure. Therefore, directions should be followed carefully. A safety data sheet (SDS) is available upon request. This and any other consumer information can be obtained by calling Merck Animal Health Customer Service at 1-800-211-3573.

Records

Keep a record of vaccine, quantity, serial number, expiration date, and place of purchase; the date and time of vaccination; the number, age, breed, and locations of chickens; names of operators performing the vaccination and any observed reactions.

Contact our sales or technical services representatives to help design a custom vaccination program.

Resources

For additional information, please see the product label.
For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

References

*Data on file, Merck Animal Health